Zentalis is a New York-based clinical-stage biopharmaceutical company that researches and develops small molecule therapeutics for the treatment of cancer.
Business Model:
Revenue: $14k
Employees: 51-200
Address: 1359 Broadway
City: New York
State: NY
Zip: 10018
Country: US
Zentalis is a New York-based clinical-stage biopharmaceutical company that researches and develops small molecule therapeutics for the treatment of cancer.
Contact Phone:
+12124333791
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/7/2020
IPO Valuation:
$621M
Ticker Symbol:
ZNTL
IPO Price:
$18/share
Amount Raised:
$190M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2022 | Post-IPO Equity | $200.2M | 7/2021 | Post-IPO Equity | $172.9M | 4/2022 | Post-IPO Equity | $0 |
Pfizer Pfizer |
12/2017 | Series B | 2 | $34M |
Matrix Capital Viking Global Investors Matrix Capital Matrix Capital Viking Global Investors Matrix Capital |
6/2021 | Post-IPO Equity | $172.9M | 4/2020 | IPO | $190M | 12/2019 | Series C | 6 | $85M |
Redmile Group Viking Global Investors Eventide Matrix Capital Perceptive Advisors Surveyor Capital Redmile Group Viking Global Investors Eventide Matrix Capital Perceptive Advisors Surveyor Capital |
5/2020 | Series A | $20M |
Tybourne Capital Management OrbiMed Asia, |
4/2022 | Post-IPO Equity | 1 | $25M |
Pfizer Pfizer |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|